Agoracom Blog Home

Archive for the ‘All Recent Posts’ Category

Kontrol $KNR $KNR.ca $KNR.c $KNRLF Receives CSA Standards Approval for BioCloud Technology $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 1:54 PM on Thursday, November 5th, 2020
kontrol-logo

 Kontrol BioCloud® a Safe Space Technology™ –

  • Announced that it has received CSA standards approval for its BioCloud® technology
  • “This is another important milestone for Kontrol and represents the continuing advancement of the BioCloud® technology,” says Paul Ghezzi, CEO Kontrol
  • CSA regulations require manufacturers of products sold in Canada to receive CSA Standards approval for electrical safety

TORONTO, ON / ACCESSWIRE / November 5, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“) is pleased to announce that it has received CSA standards approval for its BioCloud® technology.

“This is another important milestone for Kontrol and represents the continuing advancement of the BioCloud® technology,” says Paul Ghezzi, CEO Kontrol. “CSA is a Canadian standard for safety and is also accepted in jurisdictions outside Canada. In addition to CSA we continue to work on other important regional certifications including UL and CE for the United States and European markets respectively.”

Field Certification was provided by ESAFE

CSA regulations require manufacturers of products sold in Canada to receive CSA Standards approval for electrical safety. The field evaluation process follows the CSA’s SPE-1000 standard, which has three mandatory and non-destructive tests. Upon successful inspection, ESAFE validates the equipment meets CSA’s SPE-1000 standards and labels it approved. ESAFE’s labels are recognized across Canada under the Standards Council of Canada accreditation program.

ESAFE is accredited by the Standards Council of Canada (SCC), as an Inspection Body (ISO 17020) and Certification Body (ISO 17065). As an accredited agency, ESAFE is authorized to approve and label equipment for electrical safety.

www.esafe.org

About Kontrol BioCloud®

BioCloud® is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud® has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others

BioCloud® is not a medical device and the Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

About Kontrol Energy

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at: www.sedar.com.

Image: https://www.accesswire.com/users/newswire/images//10252018KNR2.pngImage: https://www.accesswire.com/users/newswire/images//10252018KNR3.pngImage: https://www.accesswire.com/users/newswire/images//10252018KNR4.png

For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud® Analyzer are subject to the risk that the Kontrol BioCloud® Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp.

$HPQ.ca NANO on Track to Start of Gen1 Reactor in December $EFL.ca $EGT.ca $ENPH $PYR.ca

Posted by AGORACOM-JC at 1:38 PM on Thursday, November 5th, 2020

The company announced today that technology provider PyroGenesis Canada Inc. (TSX-V: PYR) has updated HPQ NANO on the following PUREVAP TM Nano Silicon Reactor (“NSiR ”) development program milestones :

  • Process and mechanical engineering designs for the Gen1 PUREVAP TM NSiR have been completed, on time and on budget;
  • Gen1 fabrication will start next week, project is on schedule for a December 2020 commissioning and start.

MONTREAL, Nov. 05, 2020 — Innovative silicon solutions provider HPQ Silicon Resources Inc. (“HPQ” or “the Company”) ( TSX-V: HPQ FWB: UGE Other OTC : URAGF ) through its wholly – owned subsidiary, HPQ Nano Silicon Powders inc (“HPQ NANO”), is pleased to announce today that technology provider PyroGenesis Canada Inc. (TSX-V: PYR) has updated HPQ NANO on the following PUREVAP TM Nano Silicon Reactor (“NSiR ”) development program milestones :

  • Process and mechanical engineering designs for the Gen1 PUREVAP TM NSiR have been completed, on time and on budget;
  • Gen1 fabrication will start next week, project is on schedule for a December 2020 commissioning and start.

The process engineering phase allowed the PyroGenesis technical team to run a series of computer simulations to ensure that the system works as planned. Satisfied with the result, the mechanical engineering work needed to start the build of the Gen1 PUREVAP TM NSiR was then completed.

Bernard Tourillon, President & CEO of HPQ Silicon and HPQ NANO stated “It is very nice to see all the pieces of the puzzle falling into place We are just starting to visualize the potential commercial applications of the PUREVAP TM processes we are developing in close partnership with PyroGenesis, and I must say that I really like what we are seeing. While we are very excited by HPQ NANO material blue sky potential in the silicon battery space , we are also thrilled by our material potential in other high value markets, as this is another way for HPQ to expand its product markets by diversifying which could potentially reduce risk .”

PUREVAP TM NSiR LOW COST SPHERICAL SI LICON MATERIALS: A GAME CHANGING LEAP

Despite strong research and massive investment in Silicon material for batteries , current manufacturing processes are simply not scalable or commercially viable.

PyroGenesis, with 20+ years of experience in manufacturing plasma atomized metal powders, bring this massive knowhow to the development of the PUREVAP TM NSiR a scalable plasma-based Nano-Atomization process. PUREVAP TM NSiR will allow the low-cost transformation of metallurgical Silicon into tailor-made spherical silicon powders and/or Silicon Nanowires that battery and Electric Vehicle (EV) manufacturers are looking for.

With its capability of producing tailor made spherical silicon materials within a wide size distribution ranges (from < 0.20 m up to 5 m), the PUREVAP TM NSiR represents a game changing leap forward in resolving the issues of commercial viability and scalability.

HPQ NANO will be uniquely positioned to offer a wide spectrum of the products needed to meet the anticipated massive emerging demands from battery and EV manufactures.

PUREVAP TM QRR AND NSIR PRODUCT RANGE OPENS UP OTHER HIGH VALUE NICHE MARKET

HPQ NANO will also be uniquely positioned to offer the hydrogen sector access to a low-cost nano silicon powders alternative that can be used to extract H 2 from water.

Having the ability to use the metallurgical silicon (3N – 4N Si) to be produced by HPQ PUREVAP TM “Quartz Reduction Reactors” (QRR as feedstock for the PUREVAP TM NSiR , HPQ NANO will be able to come to market with a range of High Purity Si powder products presently used by specialty manufacturers. This represent an immediately addressable market of 100,000+ tonnes per year for HPQ NANO products. This represents 3% of the entire Silicon market which CRU 1 estimates will grow 15% by 2025.

Tourillon added “ What is truly becoming exciting about HPQ NANO is the competitive advantage we have in the massive EV and battery space, as well as, the competitive advantages we are starting to build in silicon products that we will be able to produce for alternative silicon markets. 

OTHER CORPORATE NEWS

In accordance with the agreement between HPQ-Silicon and Agoracom entered into on July 15, 2018 for the term ending July 15, 2020, HPQ-Silicon board has approved the issuance of 37,171 common shares at a deemed price of $0.38 per share to pay $14,125 for services rendered during the period from April 16, 2020 ending July 15, 2020. Each share issued pursuant to the debt settlement will have a mandatory four (4) month and one (1) day holding period from the date of closing.

As of July 15, 2020, HPQ-Silicon entered into a new agreement with Agoracom for the term ending July 15, 2021. HPQ-Silicon board has approved the new agreement and has approved the issuance of 25,223 common shares at a deemed price of $0.56 per share to pay $14,125 for services rendered during the period from July 16, 2020 ending October 15, 2020 in accordance with the new agreement. Each share issued pursuant to the debt settlement will have a mandatory four (4) month and one (1) day holding period from the date of closing. These agreement and debt settlement are subject to the approval of the TSX Venture Exchange.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and products. The Company provides its engineering and manufacturing expertise and its turnkey process equipment packages to customers in the defense, metallurgical, mining, advanced materials (including 3D printing), and environmental industries. With a team of experienced engineers, scientists and technicians working out of its Montreal office and its 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The Company’s core competencies allow PyroGenesis to provide innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified. For more information, please visit www.pyrogenesis.com .

About HPQ Silicon

HPQ Silicon Resources Inc. TSX-V: HPQ ) is a Canadian Innovative Silicon Solutions Provider.

Silicon (Si), also known as silicon metal, is one of today’s key strategic materials needed for the decarbonization of the economy and the Renewable Energy Revolution (“RER”).

Silicon is the most abundant element in earth’s crust but does not exist in its pure state and must be extracted from quartz (SiO 2 ) in what has historically been a capital and energy intensive process. That is why HPQ is building a portfolio of silicon–based products using innovative scalable processes. The target objective is to produce high value speciality Silicon products using technologies that will reduce energy consumption, GHG’s, and carbon footprint. .

Working with PyroGenesis Canada Inc. (TSX-V: PYR) , a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

  • The PUREVAP TM “Quartz Reduction Reactors” (QRR) , an innovative process (patent pending), which will permit the one step transformation of quartz (SiO 2 ) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential ;
    • HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si);
  • Through its 100% owned subsidiary HPQ NANO Silicon Powders Inc, the PUREVAP TM Nano Silicon Reactor (NSiR , a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires;
    • HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries ;
    • During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAP TM SiNR .

HPQ is also working with industry leader Apollon Solar of France to:

  • Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders;
    • The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries;
    • Develop the hydrogen generation potential of Silicon nanopowders for usage with the Gennao TM system;
    • Commercialize, exclusively in Canada, and non-exclusive in the U.S.A., the Gennao TM H2 system and the chemical powders required for the hydrolysis production of Hydrogen (“H2”).

This News Release is available on the company’s CEO Verified Discussion Forum , a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

AGORACOM Small Cap 60: Else Nutrition $BABY.ca $BABYF Has $30M In Cash And A $2.7B Shareholder To Launch Plant Based Toddler Foods Worldwide $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 12:27 PM on Thursday, November 5th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Highlights

  • $CAD 30 million in cash
  • Launched 1st Commercial Product Into US Market
  • Available via Amazon.com
  • Backed By A $2.7 Billion Dollar Global Nutrition Company;
  • Distribution agreement with one of the largest and most well regarded national fresh, organic and specialty food distributors in North America
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • Executives & Advisors From Globally Renowned Companies & Institutions
  • Received key Clean Label Certifications for Toddler Nutrition Product
  • Received Key USDA Organic Certification

Candente Gold $CDG.ca Announces Cross Distribution and Private Placement $FMG.ca $MEX.ca $AGI.ca $DSV.ca

Posted by AGORACOM at 10:59 AM on Thursday, November 5th, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/563973/hub/Candente_Gold_Hub_Logo.gif

VANCOUVER, British Columbia, Nov. 05, 2020 (GLOBE NEWSWIRE) — Candente Gold Corp. (TSXV:CDG) (“Candente Gold” and/or the “Company”) is pleased to announce that a it intends to complete a non-brokered private placement (the “Private Placement”) of up to 4,000,000 common shares (“Shares”) at a price of $0.05 per Share for gross proceeds to the Company of up to $200,000.

Joanne Freeze, President and CEO, a control person of Candente Gold Corp., will subscribe for a minimum of 50% of the Private Placement. In connection with the Private Placement, Ms. Freeze plans to complete a cross distribution, whereby she will sell up to 2,000,000 Shares from her holdings in pre-arranged trades (the “Cross”) over the facilities of the TSX Venture Exchange Inc. (the “TSXV”). Ms. Freeze will use 100% of the proceeds from the Cross to subscribe for Shares in the Private Placement.   The price at which the Cross is completed will be determined in the context of the market.

The Private Placement and the Cross remain subject to all necessary regulatory approvals, including the approval of the TSXV.

The Company intends to use the net proceeds of the Private Placement to advance the recently launched growth strategy to build a cash flowing business platform and gain access to properties with near surface exploration potential while advancing drill targets on the El Oro project, its flagship asset, and general working capital purposes. The Shares issued pursuant to the Private Placement will be subject to a four month’s hold period from the date of closing.

The issuance of Shares to Ms. Freeze pursuant to the Private Placement is considered to be a related party transaction subject to TSXV Policy 5.9 and Multilateral Instrument 61-101. Ms. Freeze intends to rely on exemptions from the formal valuation and minority shareholder approval requirements provided under sections 5.5(a) and 5.7(a) of Multilateral Instrument 61-101 on the basis that participation in the Private Placement by Ms. Freeze will not exceed 25% of the fair market value of Candente Gold Corp’s market capitalization. The Private Placement has been approved by the board of directors of the Company.

This press release will not constitute an offer to sell or the solicitation of an offer to buy nor will there be any sale of the securities in any state in which such offer, solicitation, or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.

About Candente Gold

Candente Gold has launched a comprehensive growth strategy to build a cash flowing business platform and gain access to properties with near surface exploration potential while maintaining El Oro as its flagship asset and an integral part of the overall growth strategy. The acquisition of the SDA Plant, the El Dorado historic mines and the Cocula Project signify important initial steps.

The financial benefits from Western Mexico operations and the addition of specialized personnel will translate across platforms to strengthen the Company’s efforts to explore and potentially mine areas demonstrated to contain mineralization of value. The Company is currently evaluating other properties that are complimentary to the SDA plant, El Dorado and the Cocula Project.

El Oro is a district scale gold project encompassing a well-known prolific high-grade gold dominant gold-silver epithermal vein system in Mexico.   The project covers 20 veins with past production and more than 57 veins in total, from which approximately 6.4 million ounces of gold and 74 million ounces of silver were reported to have been produced from just two of these veins (Ref. Mexico Geological Service Bulletin No. 37, Mining of the El Oro and Tlapujahua Districts. 1920, T. Flores*).

Modern understanding of epithermal vein systems indicates that several of the El Oro district’s veins hold excellent discovery potential, particularly below and adjacent to the historic workings of the San Rafael Vein, which was mined to an average depth of only 200 metres.

Joanne C. Freeze, P.Geo., President, CEO and Director and Matthew Melnyk, CPG., Director Operations and Director are Qualified Persons as defined by National Instrument 43-101 for the projects discussed above, however they have not been able to visit the El Dorado or Cocula Projects nor the SDA Plant recently due to COVID virus travel restrictions. The work discussed in the News Release is either historical and documented by public records or conducted by Mexican professionals with qualifications similar to those of QP’s registered in Canada. Ms. Freeze and Mr. Melnyk have reviewed and approved the contents of this release.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

On behalf of the Board of Candente Gold Corp.

“Joanne Freeze” P.Geo.
President, CEO and Director

For further information please contact:
Joanne Freeze                                                
President & CEO                                                                                 
Tel: + 1 (604) 689-1957                                                                 
[email protected]

Nickel Explorer Seeks to Bring New Life to Two Former Timmins Mines SPONSOR: Tartisan Nickel $TN.ca $RNX.ca $TSLA $NOB.ca $SHL.ca $CNC.ca $FPC.ca $NICO.ca

Posted by AGORACOM at 9:59 AM on Thursday, November 5th, 2020
  • Class 1 Nickel posts a two-million-tonne-plus resource at Alexo-Dundonald Project
  • Tartisan owns close to 1,700,000 shares of Class 1 Nickel (NICO:CSE) through vending of Tartisan’s Alexo-Kelex nickel asset in 2018
Tc logo in black

Crushed ore at the Alexo Mine site near Timmins in 2005.

A new nickel sulphide player has fully emerged in the Timmins camp seeking to revive a well-known piece of mining ground.

Class 1 Nickel and Technologies released a very promising new mineral resource estimate for its Alexo-Dundonald Nickel Project, 45 kilometres northeast of the city.

The Toronto-based company reported an updated estimated indicated mineral resource of 1.25 million tonnes with an average grade of 0.99 per cent of nickel, and a total estimated inferred mineral resource of 1.01 million tonnes with an average grade of 1.08 per cent.

The indicated resource count has jumped 119 per cent since the last mineral estimate in June. The inferred resource ballooned by 1,400 per cent.

The company thinks it has a turn-key project on its hands that can be fast-tracked into nickel and cobalt production with little capital expenditure.

With nickel, cobalt, copper, and platinum group elements in the ground, the company has eyes on supplying battery-grade material for the electric vehicle and stainless steel markets. Nickel sulphide is used in electric vehicle battery cathodes.

Class 1, which went public over the summer on the Canadian Securities Exchange, had been quietly assembling a 20-square-kilometre package of properties that hosted two former small-scale nickel mines along some promising exploration ground that follows a large ‘Z’-shaped group of komatiite rocks, known to contain nickel sulphide.

The project property includes two former one-pit and underground mines – the Alexo and Kelex – that ceased operations in 2005 due to low nickel prices, plus the nearby Dundonald property which contains nickel-bearing zones.

Alexo and Kelex were mined for nickel and copper three separate times around the time of the First World War, during the Great Depression and the Second World War, and lastly between 2004 and 2005.

Class 1 said much of the property has never been probed by drilling and modern geophysics. The last drilling program at Alexo-Kelex was done in 2011, and at Dundonald in 2005.

The company’s exploration program of geophysics has been focused on expanding the resource left behind at Alexo and Kelex, and probe the Dundonald property on the way to planning a drill program and eventually releasing a preliminary economic assessment report for a possible mine.

Management is currently out raising $3 million in flow-through shares for exploration.

SOURCE: https://www.northernontariobusiness.com/industry-news/mining/nickel-explorer-seeks-to-bring-new-life-to-two-former-timmins-mines-2847105

FansUnite Entertainment $FANS.ca $FUNFF Betting Platform Achieves Record Month With 433% Increase In Revenue And 713% Increase In Gross Margin Vs. October 2019 $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

Posted by AGORACOM-JC at 7:18 AM on Thursday, November 5th, 2020
  • UK Sportsbook set company records with triple-digit growth in multiple areas, led by a 433% increase in overall revenue compared to October 2019 and a total Gross win of $602K CAD during the month
  • Much of the growth was attributed to the unveiling of McBookie’s live casino games and increased activity in sports betting which resulted in $7.3M in total betting volume being placed during the month

Vancouver, British Columbia and Dundee, Scotland–(November 5, 2020) – FansUnite Entertainment Inc. (CSE: FANS) (OTC Pink: FUNFF) (“FansUnite” or the “Company”), a technology company providing leading online gaming solutions, is pleased to announce that its wholly owned subsidiary McBookie Ltd (“McBookie”) closed out October with the highest increase in monthly revenue and gross margin in the company’s 10-year history.

The UK Sportsbook set company records with triple-digit growth in multiple areas, led by a 433% increase in overall revenue compared to October 2019 and a total Gross win of $602K CAD during the month. Much of the growth was attributed to the unveiling of McBookie’s live casino games and increased activity in sports betting which resulted in $7.3M in total betting volume being placed during the month.

Casino Segment

McBookie’s new Live Casino product, encompassing multiple tables and variations of blackjack, roulette and baccarat, all with live real dealers, garnered substantial interest from online bettors.

During the month:

  • Betting volume (“Turnover”) was $5.1M CAD, an increase of 460% as compared to October 2019.
  • Gross Win was $197K CAD an increase of 679% as compared to October 2019.

Sports Segment

McBookie added new features, including ‘bet builder’, which enables online bettors to fully customize and build their bets across any number of markets, and instantly receive a price on their desired wager. The user-friendly feature combined with a full slate of English soccer fixtures and the Scottish National Soccer Team’s presence in the prestigious UEFA European Championship qualifiers, helped propel the company to new financial heights.

During the month:

  • Betting volume (“Turnover”) was $2.2M CAD, an increase of 188% as compared to October 2019.
  • Gross Win was $405K CAD, an increase of 363% as compared to October 2019.

“Despite the global pandemic, McBookie had a record-breaking month of growth in October and demonstrated how seasoned operators can not only pivot their business during challenging times but still produce results that propel their business to new heights,” said Scott Burton, CEO of FansUnite Entertainment. “With sports now starting to come back and new products in their casino offering, we have full faith that McBookie will establish themselves as the preeminent online betting platform in Scotland and expand their footprint throughout the highly sought after UK gambling industry.”

“We are very encouraged with the continued growth of the McBookie platform and continue to add new features to provide our customers with innovative solutions that will create a unique experience for them,” said Paul Petrie, founder and Director of McBookie. “With Serbia playing against Scotland in the European Championship Soccer Qualifiers, the US Masters beginning in two weeks and the Scottish Cup Final coming up in the next few months, sports are very much back in business and should see an increase in betting volume on our platform.”

About FansUnite Entertainment Inc.

FansUnite is a global sports and entertainment company, focusing on technology related to regulated and lawful online gaming and other related products. FansUnite has produced a one of a kind complete iGaming platform, Chameleon Gaming Platform, with a sports and esports focus geared for the next generation of online bettors and casino players. The platform includes products for pre-match betting, in-play betting, daily fantasy, content and a certified RNG to produce casino style chance games. The platform operates multiple B2C brands and B2B software for the online gambling industry. FansUnite also looks to acquire technology platforms and assets with high-growth potential in new or developing markets.

For further information, please contact:

Prit Singh Investor Relations at FansUnite
[email protected]
(905) 510-7636

Scott Burton Chief Executive Officer of FansUnite
[email protected]

Darius Eghdami President of FansUnite
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

DISCLAIMER REGARDING FINANCIAL INFORMATION: The preliminary financial information set forth in this release has been prepared by management based on information currently available to the Company. Accordingly, such financial information may be subject to change. All financial information contained in this news release is qualified in its entirety with reference to the Company’s audited financial statements for the financial year ended December 31, 2020, which will be filed on SEDAR as required by applicable laws. While the Company does not expect there to be any material changes to the financial information presented in this news release, to the extent that it is inconsistent with the information contained in the Company’s audited financial statements for the financial year ended December 31, 2020, the financial information contained in this news release shall be deemed to be modified or superseded by the Company’s audited financial statements. The making of a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation for purposes of applicable securities laws.

FORWARD-LOOKING STATEMENTS: Certain information contained herein may constitute “forward-‎looking information” under Canadian securities legislation. Generally, forward-looking information can be ‎identified by the use of forward-looking terminology such as “believes,” “belief,” “expects,” “intends,” ‎‎”anticipates,” “potential,” “should,” “may,” “will,” “plans,” “continue” or similar expressions to be uncertain ‎and forward-looking. Forward-looking statements may include, without limitation, statements relating to ‎future outlook and anticipated events such as: the establishment of McBookie as a preeiminent online ‎betting platform; the expansion of McBookie throughout the UK gambling industry; the effect of upcoming ‎sporting events on betting volume on the McBookie platform; the ‎Company’s unique portfolio of assets; and discussion of future plans, projections, objectives, estimates ‎and forecasts and the timing related thereto. Forward-looking statements are based on the Company’s ‎estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the ‎actual results, level of activity, performance or achievements of FansUnite to be materially different from ‎those expressed or implied by such forward-looking statements or forward-looking information. Additional ‎information regarding the risks and uncertainties relating to the Company’s business are contained under ‎the heading “Risk Factors” in the Company’s Non-Offering Prospectus dated March 27, 2020 filed on its ‎issuer profile on SEDAR at www.sedar.com and risks related to global pandemics, including the novel ‎coronavirus (COVID-19) global health pandemic, and the spread of other viruses or pathogens and influence ‎of macroeconomic developments. Accordingly, readers should not place undue reliance on forward-looking ‎statements and forward-looking information. The forward-looking statements in this news release are made ‎as of the date of this release. FansUnite disclaims and does not undertake to update or revise any forward-‎looking statements or forward-looking information, whether as a result of new information, future events or ‎otherwise, except as required by applicable securities laws.‎

Hollister $HOLL.ca $HSTRF Provides Comment on Approval of Recreational Cannabis in Arizona $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Posted by AGORACOM-JC at 10:58 PM on Wednesday, November 4th, 2020
https://prnewswire2-a.akamaihd.net/p/1893751/sp/189375100/thumbnail/entry_id/1_dd2snc3b/def_height/400/def_width/400/version/100011/type/1
  • Company comments on the successful passage of Proposition 207 – legalizing the cultivation, sale and consumption of recreational cannabis in the state of Arizona
  • “Seeing recreational Cannabis legalized in the state is an encouraging sign and is hopefully another step toward federal legalization. It should lead to increased tax revenue and job creation. The recreational cannabis market in Arizona could be valued at up to US $760 million by 2024…” Shared Jacob Cohen , Founder of Venom Extracts, Hollister’s 100% owned subsidiary based in Arizona .

VANCOUVER, BC , Nov. 4, 2020 – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the ” Company “, ” Hollister Cannabis Co. ” or ” Hollister “) a diversified cannabis branding company with products in over 280 dispensaries throughout California , and over 80 dispensaries throughout Arizona provides comment on the successful passage of Proposition 207 – legalizing the cultivation, sale and consumption of recreational cannabis in the state of Arizona .

“Seeing recreational Cannabis legalized in the state is an encouraging sign and is hopefully another step toward federal legalization. It should lead to increased tax revenue and job creation. The recreational cannabis market in Arizona could be valued at up to US $760 million by 2024 1 , significantly expanding the total addressable market for Cannabis in the state. We look forward to making our product line available to both the medical and recreational end user.” Shared Jacob Cohen , Founder of Venom Extracts, Hollister’s 100% owned subsidiary based in Arizona .

Arizona Presence

Hollister , through its 100% owned subsidiary, Venom Extracts (” Venom “), is one of Arizona’spremier extract brands and one of the state’s largest producers of award-winning medical cannabis distillate and related products. With an experienced management team and unparalleled reputation for quality, Venom prides itself as a differentiated extraction company by producing legal cannabis products at a price point that allows retailers to generate higher profits. Focused on proprietary efficiencies, Venom is able to produce more product per square foot than its competition, maintaining lower costs and risks than a typical extraction company.

Website: www.venomextracts.com

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CAbirthplace of the “American Biker”.

Website www.hollistercannabisco.com

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

 
Source:  Marijuana Business Daily

 View original content to download multimedia: http://www.prnewswire.com/news-releases/hollister-provides-comment-on-approval-of-recreational-cannabis-in-arizona-301166780.html

SOURCE Hollister Biosciences Inc.

How Cannabis-Based Therapeutics Could Help Fight #COVID Inflammation – SPONSOR: Innocan Pharma $INNO.ca $IN.ca $AXIM $LABS $CRDL.ca $TBP.ca

Posted by AGORACOM-JC at 5:51 PM on Wednesday, November 4th, 2020
Innocan-Blog
  • InnoCan Pharma and Tel Aviv University are collaborating to explore the potential for CBD-loaded exosomes (minute extracellular particles that mediate intracellular communication, including via innate and adaptive immune responses)
  • The group plans to use these loaded exosomes to target and facilitate recovery of COVID-19–damaged lung cells
  • From a broader perspective, the prospects for harnessing cannabinoids for immune modulation will be more thoroughly explored in a special issue of Cannabis and Cannabinoid Research

By: Liz Scherer

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.

Plagued by false starts, a few dashed hopes, but with perhaps a glimmer of light on the horizon, the race to find an effective treatment for COVID-19 continues. At last count, more than 300 treatments and 200 vaccines were in preclinical or clinical development (not to mention the numerous existing agents that are being evaluated for repurposing).

There is also a renewed interest in cannabinoid therapeutics — in particular, the nonpsychoactive agent cannabidiol (CBD) and the prospect of its modulating inflammatory and other disease-associated clinical indices, including SARS-CoV-2–induced viral load, hyperinflammation, the cytokine storm, and acute respiratory distress syndrome (ARDS).

Long hobbled by regulatory, political, and financial barriers, CBD’s potential ability to knock back COVID-19–related inflammation might just open doors that have been closed for years to CBD researchers.

Why CBD and Why Now?

CBD and the resulting therapeutics have been plagued by a complicated association with recreational cannabis use. It’s been just 2 years since CBD-based therapeutics moved into mainstream medicine — the US Food and Drug Administration (FDA) approved Epidiolex oral solution for the treatment of Lennox-Gastaut syndrome and Dravet syndrome, and in August, the FDA approved it for tuberous sclerosis complex.

CBD’s mechanism of action has not been fully elucidated, but on the basis of its role in immune responses — well described in research spanning more than two decades — it’s not surprising that cannabinoid researchers have thrown their hats into the COVID-19 drug development ring.

The anti-inflammatory potential of CBD is substantial and appears to be related to the fact that it shares 20 protein targets common to inflammation-related pathways, Jenny Wilkerson, PhD, research assistant professor at the University of Florida School of Pharmacy, Gainesville, Florida, explained to Medscape Medical News.

Among the various trials that are currently recruiting or are underway is one that is slated for completion this fall. CANDIDATE (Cannabidiol for COVID-19 Patients With Mild-to-Moderate COVID-19) is a randomized, controlled, double-blind study led by Brazilian researchers at the University of Sao Paulo. The study, which began recruitment this past August, enrolled 100 patients, 50 in the active treatment group (who received capsulated CBD 300 mg daily for 14 days plus pharmacologic therapy [antipyretics] and clinical measures) and 50 who received placebo.

Read Full Article: https://www.medscape.com/viewarticle/940265#vp_3

The Hummer EV, the Harley-Davidson E-Bike and Higher Ed. SPONSOR: Lomiko Metals $LMR.ca $CJC.ca $SRG.ca $NGC.ca $LLG.ca $GPH.ca $NOU.ca

Posted by AGORACOM at 4:50 PM on Wednesday, November 4th, 2020

SPONSOR: Lomiko Metals is focused on the exploration and development of minerals for the new green economy such as lithium and graphite. Lomiko has an option for 100% of the high-grade La Loutre graphite Property, Lac Des Iles Graphite Property and the 100% owned Quatre Milles Graphite Property. Lomiko is uniquely poised to supply the growing EV battery market. Click Here For More Information

  • Electrification, online learning, alternative credentials and low-cost degrees at scale.

October was a big month for us electric mobility nerds. First came the Hummer EV reveal, and next came the announcement of a Harley-Davidson electric bike.

What about this $112,595 1,000-horsepower electric vehicle, this still unknown price or specifications e-bike, has anything to do with colleges and universities? The answer to this question depends on how you think about the future of higher ed.

For cars and trucks, the destination of the future is clear, if not the timing. Eventually, at some point, batteries will replace internal combustion. Electric cars are not only emissions-free, they contain exponentially fewer moving parts than traditional vehicles. The electric car or truck of the future will be simpler to produce and will have few parts to break down. This simplicity and reliability will eventually drive down the total costs of ownership.

How long the transition to electric vehicles takes will depend on how long it takes for battery technology to improve. While coming down in price quickly, batteries large enough to power a car for any reasonable range are still hugely expensive. Beyond range anxiety, charging times remain significantly longer than filling up a gas tank, and the charging infrastructure is nowhere near as built out as gas stations.

The Hummer EV is straight out of the Tesla playbook for vehicle electrification. Start with a high-priced luxury model and then use those revenues to drive down the production costs for less expensive models. Nobody needs a $112,000 electric truck. I highly doubt that almost any Hummer EV buyers will drive the thing off-road. The Hummer EV is a status symbol, pure and simple. We may think that this thing is ridiculously over-the-top, but if it helps get us to the transition to affordable electric vehicles, we are happy that GM is going for it.

In higher ed, neither the future destination nor timing is as clear as it is with cars and trucks. There are no direct analogs for internal combustion engines or batteries across the postsecondary ecosystem.

However, we can make some broad projections about the dominant trends shaping the future of higher education. As with the need to move away from internal combustion due to the necessity to decarbonize in the face of a climate emergency, higher ed faces its own reckoning in the form of demographic shifts and diminished public funding. The environment that almost every college and university must navigate will only get more challenging in the years to come. The declining number of high school graduates in the Northeast and Midwest, combined with dwindling state support levels, will force schools to evolve their business models.

Just as GM is not doing away with gas-powered cars, colleges and universities will not abandon their core residential degree programs. These residential degree programs, however, will be increasingly joined and supplemented by online programs. Schools have no choice but to go after new markets for students, especially at the master’s level. The full-time master’s student will still exist but in ever-diminishing proportions. The future of graduate school belongs to the adult working professional, and that means online programs.

The question is, will most schools stop at online learning? I don’t think so. We are likely to see an industrywide shift to both alternative online credentials (certificates) and lower-cost online degrees at scale. If online education is like vehicle batteries, alternative credentials and low-cost scaled degrees are like autonomous driving. The future of mobility is not only electric but also self-driving (and perhaps ride sharing).

Today, autonomous vehicles are still controversial. Nobody knows when the self-driving future will arrive, and automakers are pursuing different strategies to develop these technologies. Alternative online credentials and low-cost degrees at scale are similarly controversial within higher ed. Some schools are going all out in creating that future. Others are hanging back. Like auto companies, colleges and universities that wait too long to develop the capabilities for certificates/scaled degrees might find themselves on the wrong side of the future.

What about the electric bicycle from Harley-Davidson? I think that lesson here is about a willingness to experiment. Harley might find that e-bikes serve as a gateway drug to electric motorcycles. Who knows. A technology-forward electric bike will make the Harley brand relevant to a segment of consumers that doesn’t think much about motorcycles.

Too often, colleges and universities are afraid to experiment in adjacent sectors (motorcycles to e-bikes) out of fear of damaging their brands. Many more colleges and universities could be following the lead of Georgia Tech or Boston University or Illinois by offering affordable online degrees at scale. We don’t know if these scaled online programs can be delivered with high quality or if offering them reduces the demand for existing residential programs.

The only way to figure this out, however, is to experiment. If a company as traditional as Harley-Davidson can try something new with an e-bike, shouldn’t we be willing to do the same?

SOURCE: https://www.insidehighered.com/blogs/learning-innovation/hummer-ev-harley-davidson-e-bike-and-higher-ed

D.C. Voters Appear to Approve Ballot Question to Decriminalize Psychedelic Mushrooms SPONSOR: Red Light Holland $TRIP.ca $SHRM.ca $RVV.ca $CMPS $MMED $PLNT.ca

Posted by AGORACOM at 3:38 PM on Wednesday, November 4th, 2020

SPONSOR: Red Light Holland (CSE: TRIP) is engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands. Learn more.

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564679/hub/Red_Light_Holland_Logo_2.png

A D.C. ballot initiative to decriminalize the use of magic mushrooms and other psychedelic substances had a commanding lead Tuesday after a months-long campaign in which supporters collected signatures during the height of the coronavirus pandemic.

Voters were deciding whether the nation’s capital would join a handful of cities moving to decriminalize certain psychedelic plants and fungi. The measure states it would make prosecution of those who use and sell the substances “among the Metropolitan Police Department’s lowest law enforcement priorities.”

Early results showed the measure had the approval of about three-quarters of voters.

The D.C. Board of Elections allowed Initiative 81, also known as the Entheogenic Plant and Fungus Policy Act of 2020, on the ballot amid a $700,000 campaign in which proponents collected 25,000 signatures during the pandemic. The board’s decision came amid a nationwide debate about policing and the medical value of psychedelic drugs, which supporters say are beneficial in treating trauma.

The nation’s capital appeared to become at least the fifth jurisdiction in the nation with some form of decriminalized psychedelics, joining Denver; Oakland, Calif.; Santa Cruz, Calif.; and Ann Arbor, Mich., where the city council approved decriminalization in September. Oregon voters were casting ballots Tuesday on two related statewide initiatives.

The D.C. version was introduced by Melissa Lavasani, a city government employee who used microdoses of psychedelic mushrooms to help her recover from postpartum depression. Speaking Tuesday night to supporters of the measure, she said she hopes it’s a step toward normalizing plant medicine for the purpose of healing.

“We have changed the game here. We have shifted this dialogue,” she said. “We are trying to normalize mental health.”

If approved, the ballot initiative would go to the D.C. Council for review. If the council doesn’t overturn the measure — as it did in 2018 with an initiative that would have mandated a $15-per-hour minimum wage for tipped workers — it will be sent to Congress for review. If Congress doesn’t object within 30 legislative days — as it did when it blocked D.C.’s attempt to legalize marijuana in 1998 — the initiative would go into effect.

Lindsey Walton, a spokeswoman for D.C. Council Chairman Phil Mendelson (D), said in an email he “does not have a strong position on the initiative either way” and did not plan to block it if it passed.

In February, the D.C. Board of Elections approved Initiative 81 after supporters argued that ibogaine, mescaline and the hallucinogen psilocybin, among other chemicals, help people recover from post-traumatic stress disorder and addiction.

D.C. Mayor Muriel E. Bowser (D) said late last month that she would vote against the initiative.

“It seems like the issue is not an organically D.C.-created initiative, and I don’t typically favor those. I won’t be voting for it,” she said.

D.C. Mayor Bowser says she’ll vote ‘no’ on ballot question on psychedelic mushrooms

In September, D.C. Department of Health Director LaQuandra Nesbitt said it would be “very difficult” for her to support the use of psychedelic substances without further information about their long-term side effects.

“People talk about things being plant-based as if that makes them automatically healthy,” she said, noting that opioids and tobacco also come from plants.

Supporters of the campaign, funded by a political action committee supported by, among others, natural soap company Dr. Bronner’s, plastered D.C. with signs and paid more than 150 people as much as $10 per name to collect the signatures needed to get the initiative on the ballot. One-third of the signatures were collected virtually or by mail — a first for a D.C. ballot initiative — after the D.C. Council allowed remote collection in May amid the pandemic.

Supporters suspended their collection of signatures when Bowser declared a public health emergency in March. They turned to remote collection when the D.C. Council allowed signatures to be returned electronically and by mail in May. While there was little visible campaigning against the ballot measure, D.C. voters weighed in on the proposal at the polls

Lizzy Hampton, a 20-year-old student at George Washington University, voted early at School Without Walls High School last week. She said possessing such substances shouldn’t result in criminal penalties.

“People should have access to medicinal substances recreationally,” she said.

Darlene Frederick, a 70-year-old retiree who voted at the Columbia Heights Community Center, had a different view.

“I voted no because I thought it was silly,” she said. “Hallucinogenic drugs? Maybe I’m old.”

SOURCE: https://www.washingtonpost.com/local/dc-politics/dc-magic-mushrooms-result/2020/11/03/bb929e86-1abc-11eb-bb35-2dcfdab0a345_story.html